Concepedia

Andrea Perrone

AP

24

Publications

2K

Citations

18

H-Index

2004

Active since

Affiliations

Dana-Farber Cancer Institute(Current)

The University of Texas MD Anderson Cancer Center

Merck & Co., Inc., Rahway, NJ, USA (United States)

Memorial Sloan Kettering Cancer Center

Angeles Clinic and Research Institute

Andrea Perrone is an author at Dana-Farber Cancer Institute specializing in medicine, immunology, and autoimmune disease.

ORCID

Top concepts

Publications per year

2004–2021

24

Publications

24

Evaluation of Immune-Related Response Criteria and RECIST v1.1 in Patients With Advanced Melanoma Treated With Pembrolizumab

F. Stephen Hodi, Wen-Jen Hwu, Richard Kefford et al. · Journal of Clinical Oncology · 2016 · 742 citations · Full text

Baseline Tumor Size Is an Independent Prognostic Factor for Overall Survival in Patients with Melanoma Treated with Pembrolizumab

Richard W. Joseph, Jeroen Elassaiss‐Schaap, Richard Kefford et al. · Clinical Cancer Research · 2018 · 302 citations · Full text

Peripheral blood gene expression profiling in rheumatoid arthritis

Franak Batliwalla, E C Baechler, Xu Xiao et al. · Genes and Immunity · 2005 · 153 citations

, , +8

Epigenetic Multiple Ligands: Mixed Histone/Protein Methyltransferase, Acetyltransferase, and Class III Deacetylase (Sirtuin) Inhibitors

Antonello Mai, Donghang Cheng, Mark T. Bedford et al. · Journal of Medicinal Chemistry · 2008 · 132 citations · Full text

Measurement of Tumor Volumes Improves RECIST-Based Response Assessments in Advanced Lung Cancer

P. David Mozley, Claus Bendtsen, Binsheng Zhao et al. · Translational Oncology · 2012 · 111 citations · Full text

Rows per page

1–5 of 24